Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Jan 3;24(1):12.
doi: 10.1186/s12877-023-04556-z.

A review of the enhanced CJD surveillance feasibility study in the elderly in Scotland, UK

Affiliations
Review

A review of the enhanced CJD surveillance feasibility study in the elderly in Scotland, UK

Lovney Kanguru et al. BMC Geriatr. .

Abstract

Background: Variant Creutzfeldt - Jakob disease (vCJD) arose from dietary contamination with bovine-spongiform-encephalopathy (BSE). Because of concerns that vCJD-cases might be missed in the elderly, a feasibility study of enhanced CJD surveillance on the elderly was begun in 2016. Recruitment was lower than predicted. We describe a review of the challenges encountered in that study: identification, referral, and recruitment, and the effects of actions based on the results of that review.

Methods: Review was conducted in 2017. Study data for all eligible cases identified and referred from one participating service (Anne Rowling clinic (ARC)) was curated and anonymised in a bespoke database. A questionnaire was sent out to all the clinicians in medicine of the elderly, psychiatry of old age and neurology (including ARC) specialties in NHS Lothian, exploring possible reasons for low recruitment.

Results: Sixty-eight cases were referred from the ARC (March 2016-September 2017): 25% were recruited. Most cases had been referred because of diagnostic uncertainty. No difference was seen between those recruited and the non-recruited, apart from age and referrer. Twelve of 60 participating clinicians completed the questionnaire: only 4 had identified eligible cases. High workload, time constraints, forgetting to refer, unfamiliarity with the eligibility criteria, and the rarity of eligible cases, were some of the reasons given. Suggestions as to how to improve referral of eligible cases included: regular email reminders, feedback to referrers, improving awareness of the study, visible presence of the study team, and integration of the study with other research oriented services. These results were used to increase recruitment but without success.

Conclusion: Recruitment was lower than predicted. Actions taken following a review at 21 months did not lead to significant improvement; recruitment remained low, with many families/patients declining to take part (75%). In assessing the failure to improve recruitment, two factors need to be considered. Firstly, the initial referral rate was expected to be higher because of existing patients already known to the clinical services, with later referrals being only newly presenting patients. Secondly, the unplanned absence of a dedicated study nurse. Searching digital records/anonymised derivatives to identify eligible patients could be explored.

Keywords: Creutzfeldt-Jakob Disease; Elderly; Health protection; Neurology; Prion Disease; Public health; Scotland; Surveillance; sCJD; vCJD.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

References

    1. Urwin PJ, Thanigaikumar K, Ironside JW, Molesworth A, Knight RS, Hewitt PE, Llewelyn C, Mackenzie J, Will RG. Sporadic creutzfeldt–jakob Disease in 2 plasma product recipients, United Kingdom. Synopsis 2017 23:6. - PMC - PubMed
    1. Urwin PJ, Mackenzie JM, Llewelyn CA, Will RG. Creutzfeldt–Jakob Disease and blood transfusion: updated results of the UK Transfusion Medicine Epidemiology Review study. Vox Sang. 2006;110:310–6. doi: 10.1111/vox.12371. - DOI - PubMed
    1. Creutzfeldt. - Jakob disease Surveillance in the UK. 29th Annual Report 2020. Available at: https://www.cjd.ed.ac.uk/surveillance.
    1. National CJD. Research & Surveillance Unit. Latest NCJDRSU CJD monthly statistics. Available at: Data and Reports | CJD (ed.ac.uk).
    1. Bishop MT, Hart P, Aitchison L, Baybutt HN, Plinston C, Thomson V, Tuzi NL, Head MW, Ironside JW, Will RG, Manson JC. Predicting susceptibility and incubation time of human-to-human transmission of vCJD. Lancet Neurol. 2006;5(5):393–8. doi: 10.1016/S1474-4422(06)70413-6. - DOI - PubMed

Publication types